与肥胖相关的NAFLD与慢性炎症性病共存,这种慢性炎症性病被短期口服甲福尔部分缓解
Amod Sharma1, Reza Hakkak2,3,4, Neriman Gokden5
1Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Nutrients
|July 12, 2025
概括
与肥胖相关的非酒精性脂肪性肝病 (Ob-NAFLD) 通过炎症和氧化应激导致慢性病 (CKD). 甲福明显示出一些抗炎功效,但对Ob-NAFLD大鼠的结构性损伤的影响有限.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与肥胖相关的非酒精性脂肪性肝病 (Ob-NAFLD) 与慢性病 (CKD) 患病率的增加有关.
- 了解Ob-NAFLD损伤的机制以及潜在的治疗干预措施至关重要.
研究的目的:
- 为了研究 Ob-NAFLD 对大鼠模型中损伤的影响.
- 评估甲福明在Ob-NAFLD中的潜在脏保护作用.
主要方法:
- 使用雌性Zucker大鼠 (肥胖和瘦) 来诱导Ob-NAFLD.
- 在甲福明治疗后,对脏进行了基因病理学和生物化学分析.
主要成果:
- 患有NAFLD的脏表现出管状损伤,纤维化,免疫细胞透和氧化应激标志物.
- 甲福明治疗降低了TNF-α和尼铁的水平以及免疫细胞的透.
- 甲胺对结构性损伤的影响有限.
结论:
- -NAFLD通过氧化应激,炎症和纤维化加剧了CKD.
- 短期的甲福明可以提供抗氧化和抗炎的益处,但需要进一步研究结构性脏保护.
- 替代性或组合疗法可能需要缓解Ob-NAFLD诱导的病理.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
306
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
306
Nephrotic Syndrome I : Introduction
31
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
31


